Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on ...

An official overseeing implementation of the Make America Healthy Again agenda at the Department of Health and Human Services ...

CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an ...

SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

In justifying the government's termination of $500 million in funding for mRNA vaccine projects, Health and Human Services ...

Eli Lilly stock dips despite strong Q2 results. Read my insights on obesity drug market dominance and why this selloff in LLY ...

Trump told CNBC he will initially impose a “small tariff” on pharmas in the next week or so, but will raise it to 150% in a ...

Trump demands U.S. drug prices match lowest international rates for some or face executive action. This article originally ...

Clinical research centers across the US, including the Jacksonville Center for Clinical Research, are being impacted by the ...

HHS Secretary Robert F. Kennedy Jr. says the federal government is calling off around $500 million worth of vaccine ...

Secretary Robert F. Kennedy Jr.’s decision this week to cancel hundreds of millions of dollars in mRNA vaccine funding will leave the United States unprepared ...

The decision effectively cancels projects being led by major pharmaceutical companies, including Pfizer and Moderna.